# Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet

> **NCT00735787** · PHASE4 · COMPLETED · sponsor: **Abbott** · enrollment: 81 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** Adalimumab

## Key facts

- **NCT ID:** NCT00735787
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2010-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00735787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00735787, "Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00735787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
